(ALESE) Entech SE SAS - Ratings and Ratios
Biomass, Waste To Energy, Renewable Electricity
ALESE EPS (Earnings per Share)
ALESE Revenue
Description: ALESE Entech SE SAS
Entech SE SAS, listed as ALESE on the Paris stock exchange, is a French company operating in the Renewable Electricity sub-industry. The companys stock is categorized as a common stock, indicating that shareholders have voting rights and claim on a portion of the companys assets and profits.
To assess the companys financial health and potential for growth, we need to examine key performance indicators (KPIs) and economic drivers. The Market Cap of 105.99M EUR suggests a relatively small-cap company. The absence of a P/E ratio indicates that the company is likely loss-making, which is corroborated by the negative Return on Equity (RoE) of -2.88%. This implies that the company is not generating profits from shareholder equity.
A crucial driver for companies in the Renewable Electricity sector is the global demand for clean energy, driven by environmental policies and decreasing technology costs. Key economic drivers include government subsidies, feed-in tariffs, and the overall energy demand. The companys performance is likely influenced by its ability to secure project financing, manage construction and operational risks, and navigate regulatory environments.
To evaluate the stocks potential, we should consider metrics such as revenue growth, EBITDA margins, and cash flow generation. Additionally, the companys debt-to-equity ratio and interest coverage ratio would provide insights into its capital structure and ability to meet financial obligations. A thorough analysis of these KPIs, combined with an understanding of the sectors outlook and competitive landscape, is essential to making an informed investment decision.
The stocks price movement, as indicated by its SMA20, SMA50, and SMA200, suggests an overall upward trend, with the short-term averages above the long-term average. The low Beta of 0.148 indicates that the stocks price movements are relatively uncorrelated with the broader market, potentially making it a defensive play in a diversified portfolio. However, the absence of a clear earnings growth trajectory and the negative RoE raise concerns about the companys ability to sustain long-term growth.
ALESE Stock Overview
| Market Cap in USD | 146m |
| Sub-Industry | Renewable Electricity |
| IPO / Inception |
ALESE Stock Ratings
| Growth Rating | 32.1% |
| Fundamental | 60.7% |
| Dividend Rating | - |
| Return 12m vs S&P 500 | -3.94% |
| Analyst Rating | - |
ALESE Dividends
Currently no dividends paidALESE Growth Ratios
| Growth Correlation 3m | 56.5% |
| Growth Correlation 12m | 71.2% |
| Growth Correlation 5y | -7% |
| CAGR 5y | 4.30% |
| CAGR/Max DD 5y | 0.08 |
| Sharpe Ratio 12m | -1.24 |
| Alpha | 1.35 |
| Beta | 0.557 |
| Volatility | 72.81% |
| Current Volume | 5.8k |
| Average Volume 20d | 18.8k |
| Stop Loss | 7.6 (-7.1%) |
| Signal | -1.83 |
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income (-750.9k TTM) > 0 and > 6% of Revenue (6% = 5.40m TTM) |
| FCFTA 0.04 (>2.0%) and ΔFCFTA 29.37pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 21.65% (prev 41.57%; Δ -19.92pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.05 (>3.0%) and CFO 2.43m > Net Income -750.9k (YES >=105%, WARN >=100%) |
| Net Debt (1.94m) to EBITDA (1.82m) ratio: 1.07 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.80 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (14.6m) change vs 12m ago 0.10% (target <= -2.0% for YES) |
| Gross Margin 31.85% (prev 8.46%; Δ 23.39pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 185.6% (prev 133.1%; Δ 52.50pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -0.15 (EBITDA TTM 1.82m / Interest Expense TTM 1.61m) >= 6 (WARN >= 3) |
Altman Z'' 2.46
| (A) 0.37 = (Total Current Assets 43.8m - Total Current Liabilities 24.3m) / Total Assets 52.2m |
| (B) -0.01 = Retained Earnings (Balance) -507.5k / Total Assets 52.2m |
| (C) -0.01 = EBIT TTM -242.7k / Avg Total Assets 48.5m |
| (D) 0.07 = Book Value of Equity 1.90m / Total Liabilities 26.6m |
| Total Rating: 2.46 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 60.72
| 1. Piotroski 6.50pt = 1.50 |
| 2. FCF Yield 1.42% = 0.71 |
| 3. FCF Margin 2.20% = 0.55 |
| 4. Debt/Equity 0.57 = 2.34 |
| 5. Debt/Ebitda 8.06 = -2.50 |
| 6. ROIC - WACC data missing |
| 7. RoE -2.88% = -0.48 |
| 8. Rev. Trend 78.52% = 3.93 |
| 9. Rev. CAGR 49.94% = 2.50 |
| 10. EPS Trend -12.91% = -0.32 |
| 11. EPS CAGR 41.99% = 2.50 |
What is the price of ALESE shares?
Over the past week, the price has changed by -4.33%, over one month by +9.36%, over three months by +7.63% and over the past year by +12.36%.
Is Entech SE SAS a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ALESE is around 7.48 EUR . This means that ALESE is currently overvalued and has a potential downside of -8.56%.
Is ALESE a buy, sell or hold?
What are the forecasts/targets for the ALESE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 11.4 | 39.4% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 8.3 | 1.6% |
ALESE Fundamental Data Overview
Market Cap EUR = 125.1m (125.1m EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = 111.4k EUR (last quarter)
P/S = 2.5369
P/B = 4.9595
Beta = 0.154
Revenue TTM = 90.0m EUR
EBIT TTM = -242.7k EUR
EBITDA TTM = 1.82m EUR
Long Term Debt = 1.68m EUR (from longTermDebt, last quarter)
Short Term Debt = 13.0m EUR (from shortTermDebt, last quarter)
Debt = 14.6m EUR (Calculated: Short Term 13.0m + Long Term 1.68m)
Net Debt = 1.94m EUR (from netDebt column, last quarter)
Enterprise Value = 139.7m EUR (125.1m + Debt 14.6m - CCE 111.4k)
Interest Coverage Ratio = -0.15 (Ebit TTM -242.7k / Interest Expense TTM 1.61m)
FCF Yield = 1.42% (FCF TTM 1.98m / Enterprise Value 139.7m)
FCF Margin = 2.20% (FCF TTM 1.98m / Revenue TTM 90.0m)
Net Margin = -0.83% (Net Income TTM -750.9k / Revenue TTM 90.0m)
Gross Margin = 31.85% ((Revenue TTM 90.0m - Cost of Revenue TTM 61.4m) / Revenue TTM)
Tobins Q-Ratio = 73.51 (Enterprise Value 139.7m / Book Value Of Equity 1.90m)
Interest Expense / Debt = 11.00% (Interest Expense 1.61m / Debt 14.6m)
Taxrate = unknown
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 1.80 (Total Current Assets 43.8m / Total Current Liabilities 24.3m)
Debt / Equity = 0.57 (Debt 14.6m / last Quarter total Stockholder Equity 25.6m)
Debt / EBITDA = 8.06 (Net Debt 1.94m / EBITDA 1.82m)
Debt / FCF = 7.40 (Debt 14.6m / FCF TTM 1.98m)
Total Stockholder Equity = 26.1m (last 4 quarters mean)
RoA = -1.44% (Net Income -750.9k, Total Assets 52.2m )
RoE = -2.88% (Net Income TTM -750.9k / Total Stockholder Equity 26.1m)
RoCE = -0.87% (Ebit -242.7k / (Equity 26.1m + L.T.Debt 1.68m))
RoIC = unknown (NOPAT none, Invested Capital 43.6m, Ebit -242.7k)
WACC = unknown (E(125.1m)/V(139.8m) * Re(8.07%)) + (D(14.6m)/V(139.8m) * Rd(11.00%) * (1-Tc(none)))
Shares Correlation 5-Years: 90.0 | Cagr: 0.90%
Discount Rate = 8.07% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 70.37% ; FCFE base≈1.98m ; Y1≈1.30m ; Y5≈593.9k
Fair Price DCF = 0.79 (DCF Value 11.6m / Shares Outstanding 14.7m; 5y FCF grow -40.0% → 3.0% )
Revenue Correlation: 78.52 | Revenue CAGR: 49.94%
Rev Growth-of-Growth: -2.07
EPS Correlation: -12.91 | EPS CAGR: 41.99%
EPS Growth-of-Growth: -33.85